Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CINNASIL

RESCINNAMINE

Standard Dose
0.5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CINNASIL is listed in Drugs@FDA under application 084736 (ANDA).

Marketing status: Discontinued Active ingredient RESCINNAMINE Form and strength CAPSULE;ORAL - 0.5MG Sponsor PANRAY Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview CINNASIL is listed in Drugs@FDA under application 084736 (ANDA). Marketing status: Discontinued Active ingredient RESCINNAMINE Form and strength CAPSULE;ORAL - 0.5MG Sponsor PANRAY Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.